Related Experiment Video
Updated: Mar 27, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Deep infection after hip arthroplasty: staying current with change
M R Whitehouse1, M C Parry2, S Konan3
1University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Abstract:
Periprosthetic joint infection (PJI) complicates between 0.5% and 1.2% primary total hip arthroplasties (THAs) and may have devastating consequences. The traditional assessment of patients suffering from PJI has involved the serological study of inflammatory markers and microbiological analysis of samples obtained from the joint space. Treatment has involved debridement and revision arthroplasty performed in either one or two stages. We present an update on the burden of PJI, strategies for its diagnosis and treatment, the challenge of resistant organisms and the need for definitive evidence to guide the treatment of PJI after THA.
Insights
Periprosthetic joint infection (PJI) affects 0.5-1.2% of hip replacements. This review updates on PJI diagnosis, treatment challenges, resistant microbes, and evidence gaps for total hip arthroplasty care.
Area of Science:
- Orthopedics
- Infectious Diseases
- Biomedical Engineering
Background:
- Periprosthetic joint infection (PJI) is a severe complication following total hip arthroplasty (THA), occurring in 0.5% to 1.2% of primary procedures.
- PJI can lead to devastating consequences, necessitating complex management strategies.
- Traditional diagnostic methods include serological inflammatory markers and joint fluid microbiological analysis.
Purpose of the Study:
- To provide an updated overview of the burden of periprosthetic joint infection (PJI) after total hip arthroplasty (THA).
- To review current diagnostic and treatment strategies for PJI.
- To highlight challenges posed by resistant organisms and the need for evidence-based treatment guidelines.
Main Methods:
- Literature review and synthesis of recent studies on PJI.
- Analysis of diagnostic approaches, including serological markers and microbiological sampling.
- Evaluation of treatment modalities such as debridement and staged or one-stage revision arthroplasty.
Main Results:
- PJI remains a significant complication with substantial patient impact.
- Diagnostic accuracy and treatment efficacy are continually evolving.
- The emergence of antibiotic-resistant organisms presents a growing challenge in PJI management.
Conclusions:
- There is a critical need for robust, evidence-based guidelines to direct the management of PJI after THA.
- Further research is required to address treatment uncertainties, particularly concerning resistant pathogens.
- Optimizing PJI diagnosis and treatment is essential for improving patient outcomes in THA.
